Affiliations 

  • 1 Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 2 Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 3 Department of Neurology, National Taiwan University Hospital Taipei, Taipei, Taiwan
  • 4 Duke-National University of Singapore Medical School, Singapore
  • 5 Department of Neurology, Seoul National University Hospital, College of Medicine, Seoul National University, Seoul, Republic of Korea
  • 6 Department of Neurology, National Taiwan University Hospital Bei-Hu branch, Taipei, Taiwan
  • 7 Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore
  • 8 Personalised Medicine Centre, Health Futures Institute, Murdoch University, Perth, Australia
  • 9 The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China
  • 10 Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 11 Department of Physiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 12 Department of Radiology, Subang Jaya Medical Centre, Selangor, Malaysia
  • 13 Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA
  • 14 Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom
  • 15 DataTecnica LLC, Washington, DC 20037, USA
  • 16 Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
  • 17 Translational Neurogenomics Group, ANZAC Research Institute, Sydney Local Health District and Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
  • 18 Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
  • 19 Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
  • 20 Neurogenetics Research Center, IRCCS Mondino Foundation, 27100 Pavia, Italy
medRxiv, 2026 Jun 22.
PMID: 42396327 DOI: 10.64898/2026.06.11.26354827

Abstract

INTRODUCTION: GCH1 has been implicated in Parkinson's disease (PD), but its risks variants and associations are not well defined.

OBJECTIVES: To investigate the clinical relevance and PD risk associated with the GCH1 p.Ser80Asn variant.

METHODS: We first identified a segregating GCH1 p.Ser80Asn variant in a Malaysian Chinese PD family via whole genome sequencing (WGS). We assessed its risk association using multi-ancestry WGS data from the Global Parkinson's Genetics Program (GP2) (n=22,372PD vs n=8,826Controls) and meta-analysis of East Asian (EAS) cohorts (n=4,712PD vs 38,733Controls). Clinico-demographic details of affected variant carriers were collated.

RESULTS: The GCH1 p.Ser80Asn variant was enriched in GP2 EAS PD populations (n=9/2,757; 0.33%) but not detected in other ancestries. Meta-analysis revealed increased PD risk in EAS populations (odds ratio:5.1; 95%CI:2.3-10.7; p=2.89×10-5). Affected carriers (mean age at onset:56.3±12.5 years) had additional occurrence of dystonia, while dementia was rare.

CONCLUSIONS: The GCH1 p.Ser80Asn variant is a rare, EAS-enriched risk variant for PD.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.